These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chemotaxis in yersinia arthritis. In vitro stimulation of neutrophil migration by HLA--B27 positive and negative sera. Repo H, Leirisalo M, Tiilikainen A, Laitinen O. Arthritis Rheum; 1982 Jun; 25(6):655-61. PubMed ID: 6980007 [Abstract] [Full Text] [Related]
3. Chemotaxis in yersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro. Leirisalo M, Repo H, Tiilikainen A, Kosunen TU, Laitinen O. Arthritis Rheum; 1980 Sep; 23(9):1036-44. PubMed ID: 7417352 [Abstract] [Full Text] [Related]
4. Enhanced neutrophil migration in vivo HLA B27 positive subjects. Koivuranta-Vaara P, Repo H, Leirisalo M, Kiistala U, Osterman T, Vapaatalo H. Ann Rheum Dis; 1984 Apr; 43(2):181-5. PubMed ID: 6370148 [Abstract] [Full Text] [Related]
5. Polymorphonuclear leucocyte function and previous yersinia arthritis: enhanced chemokinetic migration and oxygen radical production correlate with the severity of the acute disease. Koivuranta-Vaara P, Leirisalo-Repo M, Repo H. Ann Rheum Dis; 1987 Apr; 46(4):307-13. PubMed ID: 3592787 [Abstract] [Full Text] [Related]
6. Neutrophil function and HLA-B27. Superoxide production and yersinicidal activity of neutrophils from patients with previous yersinia arthritis. Repo H, Leirisalo-Repo M, Skurnik M, Tiilikainen A. Med Biol; 1984 Apr; 62(2):91-4. PubMed ID: 6088912 [Abstract] [Full Text] [Related]
7. Effects of HLA-B27 positive and negative sera on migration of polymorphonuclear leukocytes in vitro. Repo H, Leirisalo-Repo M, Koskimies S. Clin Exp Rheumatol; 1988 Apr; 6(3):227-31. PubMed ID: 3263238 [Abstract] [Full Text] [Related]
8. Yersinia arthritis, immune functions and histocompatibility antigens. Repo H, Leirisalo-Repo M, Gripenberg M, Koskimies S, Kontiainen S, Laitinen O. Acta Pathol Microbiol Immunol Scand C; 1986 Dec; 94(6):245-52. PubMed ID: 2953168 [Abstract] [Full Text] [Related]
12. Antibody producing capacity to the bacteriophage phi X174 in yersinia arthritis. Bucknall R, Leirisalo-Repo M, Laitinen O, Jones JV. Ann Rheum Dis; 1987 Dec; 46(12):883-8. PubMed ID: 2962540 [Abstract] [Full Text] [Related]
13. Oxygen radical production and trapping in subjects with previous Yersinia infection. Ristola M, Metsä-Ketelä T, Leirisalo-Repo M, Repo H. Inflammation; 1992 Jun; 16(3):273-83. PubMed ID: 1323531 [Abstract] [Full Text] [Related]
14. HLA phenotypes in patients with rheumatic fever, rheumatic heart disease, and Yersinia arthritis. Leirisalo M, Laitinen O, Tiilikainen A. J Rheumatol Suppl; 1977 Jun; 3():78-83. PubMed ID: 266605 [Abstract] [Full Text] [Related]
15. Neutrophil function and HLA-B27. Repo H, Leirisalo M, Koivuranta P, Osterman T, Kiistala U, Gahmberg CG, Vapaatalo H, Tiilikainen A, Laitinen O. Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):168-71. PubMed ID: 6606470 [Abstract] [Full Text] [Related]
16. Immune function in patients with previous yersinia arthritis: lymphocyte responses to PHA and Staphylococcus aureus strain Cowan I. Repo H, Leirisalo-Repo M. Acta Pathol Microbiol Immunol Scand C; 1986 Feb; 94(1):39-43. PubMed ID: 3487200 [Abstract] [Full Text] [Related]
18. Relation between HLA-B27 and clinical features in patients with yersinia arthritis. Laitinen O, Leirisalo M, Skylv G. Arthritis Rheum; 1977 Jun; 20(5):1121-4. PubMed ID: 869958 [Abstract] [Full Text] [Related]
19. Phagocyte function in reactive arthritis. Leirisalo-Repo M, Repo H. Scand J Rheumatol Suppl; 1988 Jun; 76():73-7. PubMed ID: 3075090 [Abstract] [Full Text] [Related]